Comparison of perinatal outcomes in facilities before and after Global Network's Helping Babies Breathe Implementation Study in Nagpur, India.

Asphyxia Community births Essential newborn care Facility births Global Health Helping babies breathe Implementation science India Neonatal mortality Perinatal mortality Pre-post design Stillbirths Training

Journal

BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799

Informations de publication

Date de publication:
04 Sep 2019
Historique:
received: 16 01 2019
accepted: 27 08 2019
entrez: 6 9 2019
pubmed: 6 9 2019
medline: 15 2 2020
Statut: epublish

Résumé

The Helping Babies Breathe (HBB) educational program focuses on training of first-level birth attendants in neonatal resuscitation skills for the first minute of life (The Golden Minute). Pre-post studies of HBB implementation in sub-Saharan Africa and Asia have shown reductions in facility-based very early neonatal mortality and stillbirth rates. However, the Global Network pre-post HBB Implementation Study (GN-HBB-IS) found no difference in day 7 perinatal mortality rates (PMR-D7) among births to women participating in the Global Network's Maternal and Newborn Health Registry. To address potential differences in perinatal outcomes in births occurring in facilities that implemented HBB vs. all births occurring in the communities served by facilities that implemented HBB, we compared day-1 perinatal mortality rates (PMR-D1) among births occurring pre and post HBB implementation in facilities in Nagpur, India, one of the 3 sites participating in the GN-HBB-IS. We hypothesized that there would be a 20% decrease in the Nagpur facility based PMR-D1 in the 12 months post GN HBB implementation from the pre-period. We explored pre-post differences in stillbirth rates (SBR) and day-1 neonatal mortality rates (NMR-D1). Of the 15 facilities trained for the GN-HBB-IS, 13 participated in the Nagpur HBB Facility Study (Nagpur-HBB-FS). There were 38,078 facility births in the 12 months before the GN-HBB-IS and 40,870 facility births in the 12 months after the GN-HBB-IS. There was 11% overlap between the registry births analyzed in the GN-HBB-IS and the facility births analyzed in the Nagpur-HBB-FS. In the Nagpur-HBB-FS, there was a pre-post reduction of 16% in PMR-D1 (p = 0.0001), a 14% reduction in SBR (p = 0.002) and a 20% reduction NMR-D1 (p = 0.006). In the Nagpur-HBB-FS, PMR-D1, stillbirths and NMR-D1 were significantly lower after HBB implementation. These benefits did not translate to improvements in PMR-D7 in communities served by these facilities, possibly because facilities in which HBB was implemented covered an insufficient proportion of community births or because additional interventions are needed after day 1 of life. Further studies are needed to determine how to translate facility-based improvements in PMR-D1 to improved neonatal survival in the community. The Global Network HBB Implementation Study (GN-HBB-IS) was registered at ClinicalTrials.gov: NCT01681017 .

Sections du résumé

BACKGROUND BACKGROUND
The Helping Babies Breathe (HBB) educational program focuses on training of first-level birth attendants in neonatal resuscitation skills for the first minute of life (The Golden Minute). Pre-post studies of HBB implementation in sub-Saharan Africa and Asia have shown reductions in facility-based very early neonatal mortality and stillbirth rates. However, the Global Network pre-post HBB Implementation Study (GN-HBB-IS) found no difference in day 7 perinatal mortality rates (PMR-D7) among births to women participating in the Global Network's Maternal and Newborn Health Registry. To address potential differences in perinatal outcomes in births occurring in facilities that implemented HBB vs. all births occurring in the communities served by facilities that implemented HBB, we compared day-1 perinatal mortality rates (PMR-D1) among births occurring pre and post HBB implementation in facilities in Nagpur, India, one of the 3 sites participating in the GN-HBB-IS.
METHODS METHODS
We hypothesized that there would be a 20% decrease in the Nagpur facility based PMR-D1 in the 12 months post GN HBB implementation from the pre-period. We explored pre-post differences in stillbirth rates (SBR) and day-1 neonatal mortality rates (NMR-D1).
RESULTS RESULTS
Of the 15 facilities trained for the GN-HBB-IS, 13 participated in the Nagpur HBB Facility Study (Nagpur-HBB-FS). There were 38,078 facility births in the 12 months before the GN-HBB-IS and 40,870 facility births in the 12 months after the GN-HBB-IS. There was 11% overlap between the registry births analyzed in the GN-HBB-IS and the facility births analyzed in the Nagpur-HBB-FS. In the Nagpur-HBB-FS, there was a pre-post reduction of 16% in PMR-D1 (p = 0.0001), a 14% reduction in SBR (p = 0.002) and a 20% reduction NMR-D1 (p = 0.006).
CONCLUSIONS CONCLUSIONS
In the Nagpur-HBB-FS, PMR-D1, stillbirths and NMR-D1 were significantly lower after HBB implementation. These benefits did not translate to improvements in PMR-D7 in communities served by these facilities, possibly because facilities in which HBB was implemented covered an insufficient proportion of community births or because additional interventions are needed after day 1 of life. Further studies are needed to determine how to translate facility-based improvements in PMR-D1 to improved neonatal survival in the community.
TRIAL REGISTRATION BACKGROUND
The Global Network HBB Implementation Study (GN-HBB-IS) was registered at ClinicalTrials.gov: NCT01681017 .

Identifiants

pubmed: 31484498
doi: 10.1186/s12884-019-2480-7
pii: 10.1186/s12884-019-2480-7
pmc: PMC6724302
doi:

Banques de données

ClinicalTrials.gov
['NCT01681017']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

324

Subventions

Organisme : NICHD NIH HHS
ID : UG1 HD078439
Pays : United States

Références

Resuscitation. 1999 Feb-Mar;40(2):71-88
pubmed: 10225280
J Child Neurol. 2001 Nov;16(11):781-92
pubmed: 11732762
Acta Paediatr. 1992 Oct;81(10):739-44
pubmed: 1421875
Lancet. 2005 Mar 12-18;365(9463):977-88
pubmed: 15767001
J Perinatol. 2005 Mar;25 Suppl 1:S82-91
pubmed: 15791282
Pediatrics. 2005 Feb;115(2 Suppl):519-617
pubmed: 15866863
Int J Gynaecol Obstet. 2009 Oct;107 Suppl 1:S5-18, S19
pubmed: 19815202
Int J Gynaecol Obstet. 2009 Oct;107 Suppl 1:S47-62, S63-4
pubmed: 19815203
Int J Gynaecol Obstet. 2009 Oct;107 Suppl 1:S21-44, S44-5
pubmed: 19815204
N Engl J Med. 2010 Feb 18;362(7):614-23
pubmed: 20164485
Lancet. 2010 Jun 5;375(9730):1988-2008
pubmed: 20546887
PLoS Med. 2011 Aug;8(8):e1001080
pubmed: 21918640
Lancet. 2012 Feb 4;379(9814):445-52
pubmed: 22244654
Int J Gynaecol Obstet. 2012 Sep;118(3):190-3
pubmed: 22738806
Pediatrics. 2013 Feb;131(2):e344-52
pubmed: 23339215
Pediatrics. 2013 Feb;131(2):e353-60
pubmed: 23339223
BMC Pregnancy Childbirth. 2014 Mar 26;14:116
pubmed: 24670013
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
Pediatrics. 2015 Jan;135(1):e59-65
pubmed: 25489010
Circulation. 2015 Nov 3;132(18 Suppl 2):S543-60
pubmed: 26473001
PLoS One. 2015 Dec 11;10(12):e0144443
pubmed: 26659661
Lancet. 2016 Feb 6;387(10018):587-603
pubmed: 26794078
BMC Pregnancy Childbirth. 2016 Aug 15;16(1):222
pubmed: 27527831
BMC Pregnancy Childbirth. 2016 Nov 22;16(1):364
pubmed: 27875999
BMJ Paediatr Open. 2017 Nov 16;1(1):e000183
pubmed: 29637172
Lancet Glob Health. 2019 Jun;7(6):e710-e720
pubmed: 31097275
Singapore Med J. 1997 Nov;38(11):485-7
pubmed: 9550910

Auteurs

Archana Patel (A)

Lata Medical Research Foundation, Nagpur, India.

Akash Bang (A)

Mahatma Gandhi Institute of Medical Sciences, Sewagram, Maharashtra State, 442102, India. drakashbang@gmail.com.

Kunal Kurhe (K)

Lata Medical Research Foundation, Nagpur, India.

Savita Bhargav (S)

Lata Medical Research Foundation, Nagpur, India.

Amber Prakash (A)

Lata Medical Research Foundation, Nagpur, India.

Spoorthy Arramraj (S)

Ankura Hospital for Women and Children, Hyderabad, India.

Patricia L Hibberd (PL)

Boston University School of Public Health, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH